Jaime Rosenberg

An analysis of data from between 2010 and 2017 found that Medicaid expansion promoted HIV testing without increasing HIV risk behavior among nonelderly adults.

Between 2017 and 2018, the percentage of adolescents who were up-to-date on the vaccine series increased from 48.6% to 51.1%, which was attributed to an increase among boys only.

The proposed changes would implement revisions to the 4-decade-old 42 CFR Part 2, which requires confidentiality of patient records created by federally-assisted substance use disorder treatment programs.

Women participating in a randomized clinical trial were able to significantly reduce their alcohol intake regardless of medication assignment and subsequently improve rates of viral suppression.

Women who reach menopause at an early age had a 31% increased risk of all-cause mortality if they had ever used hormone replacement therapy.

The update to the 2013 recommendation includes a grade B recommendation that women with a personal history of breast, ovarian, tubal, or peritoneal cancer, and women with ancestry associated with BRCA1/2 mutations be assessed for the genetic mutations.

In a highly anticipated decision, the FDA on Monday rejected accelerated approval for Sarepta Therapeutics’ second Duchenne drug, handing the drug maker a surprising blow that has some questioning the motivation behind the decision.

Chronic pain, obesity and cancer, multiple myeloma patterns, pancreatic cancer screening updates, and more.

Coverage from the National Comprehensive Cancer Network Policy Summit held June 27, 2019, in Washington, DC.

The panel voted against recommending the prevention pill for use in cisgender women due to inadequate data on efficacy in this patient population.

FDA's approval of entrectinib for neurotrophic tyrosine receptor kinase (NTRK) fusion-positive tumors represents a new paradigm in cancer treatment; It treats a cancer based on a common biomarker seen across different tumors rather than based on the location in the body where the cancer originated. The FDA also gave approval to entrectinib for the treatment of adults with metastatic non–small cell lung cancer whose tumors are ROS1 positive.

Under a proposed rule released today, the agency would require new health warnings on cigarette packages and advertisements, which would feature pictures and images depicting some of the lesser-known health risks, including bladder cancer and heart disease.

The viewpoint paints a picture of a challenge that is 2-fold: a growing amount of people are injecting opioids in rural communities, which is an emerging risk factor for HIV transmission, and these communities often lack the infrastructure or resources to prevent, diagnose, and treat HIV.

Using data from 330 millennials responding to an online survey in December 2018, a Welltok survey revealed that 78% of the age group feel that employers are not doing enough to support their well-being.

New research is suggesting that measuring the pulse wave at a menopausal woman’s wrist may explain the increase in cardiovascular disease risk during menopause better than a standard blood pressure measurement.

Researchers found that they were able to use a small molecule called ZL0580 to modify bromodomain-containing protein 4 to suppress HIV.

Weeks after the first 2 anticancer biosimilars entered the US market, OneOncology announced that its partner practices have already started administering the drugs.

The study of more than 21,000 patients showed that after a median follow-up of 2.1 years, patients with comorbid chronic obstructive pulmonary disease (COPD) had significantly worse overall survival and progression-free survival.

From preadolescence to young adulthood, the rate of self-reported nonadherence increased from 31% to half of study participants. Concurrently, the prevalence of a detectable viral load increased from 16% to 40%.

In 2018, just 1 naloxone prescription was dispensed for every 69 high-dose opioid prescriptions.

Following the state's approval, the ClonoSEQ Assay will be available in all 50 states.

Daiichi Sankyo has received approval for its treatment for the rare joint tumor.

The National Comprehensive Cancer Network (NCCN) has published a set of recommendations for the treatment of small bowel adenocarcinoma, representing the first treatment guidelines in the United States for the rare type of cancer.

In the past 3 decades, drug overdoses have killed approximately 870,000 people. Since the first wave of the opioid epidemic began in the 1990s, the epidemic has expanded to include synthetic, illicit drugs, including heroin and fentanyl. As new CDC data and other studies offer updates on the epidemic, here are 5 things to know.

A study published today in JAMA Oncology found that higher cancer mortality rates among people living with HIV remain even after adjusting for variations in cancer treatment, especially in breast and prostate cancers.

High costs of care, particularly for prescription drugs, dominated a discussion of cancer care at the state level during the June 27, 2019, National Comprehensive Cancer Network Policy Summit in Washington, DC.

The Safe Importation Action Plan offers 2 avenues importing drugs originally intended for foreign markets.

The University of Michigan Center for Value-Based Insurance Design (V-BID), in collaboration with a group of healthcare stakeholders, has announced the details of V-BID X, a template for reducing cost sharing for certain high-value services and raising cost sharing for certain low-value services while not increasing premiums or deductibles.

Chronic kidney disease comorbid with chronic obstructive pulmonary disease (COPD) was associated with increased mortality, independent of other cardiovascular comorbidities.

The prevalence of chronic obstructive pulmonary disease (COPD) was nearly 50% higher among patients with arthritis compared with those without arthritis, even after adjusting for sociodemographic characteristics, risk behaviors, frequent distress, and asthma status.